Browse studies

Find your next paid study

27,333 recruiting studies available now

Newest first Highest paying

Observational

Study to Evaluate the Clinical Utility of Radiation Exposure Reduction (SECURE): Multi-site Rampart Guardian Peripheral Trial

Radiation Protection

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Baylor Research InstituteNCT07467720

Observational

Detecting Change in Muscle Parameters, Pain, and Function With Neuromuscular Electrical Stimulation Treatment in Individuals Living With Transtibial Amputation

The proposal aims to investigate a non-invasive, cost-effective method for rebuilding muscle mass in individuals with transtibial limb loss. Maintaining a heal…

Amputation

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Sara Peterson-SnyderNCT06830876

Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation

This study explores how a specific genetic mutation of leucine-rich repeat kinase 2 (LRRK2) affects individuals with Parkinson's disease (PD), comparing those …

Parkinson Disease

Estimated

~$10 – $750

Actual pay is set by the research site.

University of MichiganNCT07642908

Phase 1

PHASE 1/2A OPEN-LABEL CLINICAL TRIAL EVALUATING VBC101, AN EGFR AND CMET TARGETED BI-SPECIFIC ANTIBODY DRUG CONJUGATE, IN PARTICIPANTS WITH ADVANCED SOLID TUMOR MALIGNANCIES

This is a multicenter, open-label, multiple-dose, FIH Phase 1/2a trial. The Phase 1 portion adopts an accelerated titration for the first dose level, followed …

Participants With Advanced Solid Tumor Malignancies

Estimated

~$150 – $4,200

Actual pay is set by the research site.

VelaVigo Bio IncNCT07136779

Observational

Advancing Lung Cancer Screening One Text at a Time

The purpose of this study is to assess the feasibility, acceptability, and preliminary impact of text messaging to promote lung cancer screening.

Lung Cancer Screening

Estimated

~$10 – $750

Actual pay is set by the research site.

University of RochesterNCT07227480

Phase 3

A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Iptacopan (LNP023) in Idiopathic Immune-complex-mediated Membranoproliferative Glomerulonephritis (IC-MPGN)

This study is designed as a multicenter, randomized, double-blind, parallel group, placebo-controlled study to evaluate the efficacy and safety of iptacopan (L…

IC-MPGN

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Novartis PharmaceuticalsNCT05755386

Observational

Advancing Suicide Intervention Strategies for Teens During High Risk Periods

To inform the effective management of adolescent suicide risk by evaluating promising treatments and developing the evidence-base for interventions that are we…

Suicide AttemptsSuicidal IdeationSuicide and Self-harm+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Seattle Children's HospitalNCT05078970

Observational

IDEAL: Implementing an Effective Diabetes intervEntion Among Low-income Immigrants

The goal of this IDEAL project is to examine the effectiveness and implementation process of the video-based Diabetes Self-Management Education and Support (DS…

Type 2 Diabetes

Estimated

~$10 – $1,125

Actual pay is set by the research site.

NYU Langone HealthNCT06319703

Observational

Social and Environmental Determinants of Breast Cancer Survivorship: the Black Breast Cancer Survivor's Intervention (BBCSI)

The goal of this research study is to learn about the effects of the BBCSI course on the quality of life of Black breast cancer survivors. A community-based a…

Breast Cancer

Estimated

~$10 – $750

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT06885203

Phase 1

An Intravenous, Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers

Background: Heart disease is the leading cause of death, disability, and healthcare expense in the United States. Researchers think a new drug called Fx-5A ma…

Cardiovascular Disease

Estimated

~$500 – $6,750

Actual pay is set by the research site.

National Heart, Lung, and Blood Institute (NHLBI)NCT04216342

Phase 2

A Phase 2 Study of Preoperative Pembrolizumab and Chemotherapy Followed by Adjuvant Pembrolizumab in Resectable Locoregionally Recurrent Head and Neck Squamous Cell Carcinoma

This research study is evaluating effectiveness and safety of a combination of immunotherapy drug, pembrolizumab, with chemotherapy, as a possible treatment be…

Head and Neck Squamous Cell CarcinomaHead and Neck CancerResectable Head and Neck Squamous Cell Carcinoma+2 more

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Dana-Farber Cancer InstituteNCT05726370

Observational

Less Pain, More Game: Efficacy of Red Kinesiology Tape on Carpal Tunnel-Like Symptoms and Performance in Esports Gamers

The goal of this clinical trial is to learn if dorsally applied kinesiology tape is an effective conservative treatment for symptoms of carpal tunnel syndrome …

Carpal Tunnel Syndrome

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Nevada, Las VegasNCT06757062